SurgoCap Partners LP — NVIDIA CORPORATION NVDA: Quarterly 13F Position History
SurgoCap Partners LP has reported NVIDIA CORPORATION (NVDA) on 10 13F-HR filings in Pactolio's tracked window, first appearing in Q4 2023. As of Q1 2026, the position is sized at 1,008,073 shares ($175.8M market value, 5.87% of the equity book). Quarter-over-quarter share count change: + 385,534 (+61.9%) .
- 1,008,073Shares Held (Latest Filing)
- $175.8MReported Market Value (Latest Filing)
- 5.87%Portfolio Weight (% of 13F Equity Book)
- +385,534Quarter-over-Quarter Share Change
- +$59.7MQuarter-over-Quarter Value Change
- 1,040,120Peak Reported Shares (Historical)
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 10 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q1 2026 | 1,008,073 | +385,534 | +61.9% | $175.8M | 5.87% | $174.40 |
| Q4 2025 | 622,539 | +622,539 | — | $116.1M | 3.21% | $186.50 |
| Q3 2025 | 0 | 0 | — | $0 | 0.00% | — |
| Q2 2025 | 0 | 0 | — | $0 | 0.00% | — |
| Q1 2025 | 0 | 1,040,120 | -100.0% | $0 | 0.00% | — |
| Q4 2024 | 1,040,120 | +1,040,120 | — | $139.7M | 8.09% | $134.29 |
| Q3 2024 | 0 | 857,606 | -100.0% | $0 | 0.00% | — |
| Q2 2024 | 857,606 | +671,538 | +360.9% | $105.9M | 6.20% | $123.54 |
| Q1 2024 | 186,068 | +27,704 | +17.5% | $168.1M | 9.02% | $903.56 |
| Q4 2023 | 158,364 | — | — | $78.4M | 5.54% | $495.22 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.
When did SurgoCap Partners LP first disclose a NVDA position in 13F-HR filings?
SurgoCap Partners LP first reported NVIDIA CORPORATION (NVDA) on its 13F-HR filing for the period ending 2023-12-31 (Q4 2023). The position has appeared on 10 reported quarters within Pactolio's tracked window.
What was SurgoCap Partners LP's most recent quarter-over-quarter share-count change in NVDA?
Between Q4 2025 and Q1 2026, SurgoCap Partners LP added 385,534 shares of NVDA (+61.9%), bringing the total reported position to 1,008,073 shares at a market value of $175.8M.
Does the implied price-per-share represent SurgoCap Partners LP's cost basis in NVDA?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.